Charles Piazza

Fortis Life Sciences LLC is an American life sciences company that was established in 2020 with a mission to offer world-class products and customer experience. The company is based in the United States and has subsidiaries in Canada and the United States. The company has built a portfolio of high-quality products and brands serving various life sciences end markets, including diagnostic, therapeutic, and research. Fortis Life Sciences offers word-class reagents, tools, materials, and custom services for their research, diagnostic, and therapeutic customers. The company was founded in 2020 by Brian S. Kim and Ken Yoon, with Brian S. Kim serving as the CEO since then.

Accellix, Inc. develops in-vitro diagnostic systems. Its Accellix platform is an affordable tabletop diagnostic device with single-use assay cartridges that does not require extensive training nor involve complex operational processes. The firm’s product is an application for the rapid identification of sepsis, a condition associated with high morbidity and mortality with no existing rapid diagnostic test. The company was founded in 2009 by Julien Meissonnier and Harvey Kasdan and is headquartered in San Jose, CA.

Fortis Life Sciences LLC is an American life sciences company that was established in 2020 with a mission to offer world-class products and customer experience. The company is based in the United States and has subsidiaries in Canada and the United States. The company has built a portfolio of high-quality products and brands serving various life sciences end markets, including diagnostic, therapeutic, and research. Fortis Life Sciences offers word-class reagents, tools, materials, and custom services for their research, diagnostic, and therapeutic customers. The company was founded in 2020 by Brian S. Kim and Ken Yoon, with Brian S. Kim serving as the CEO since then.

Fortis Life Sciences LLC is an American life sciences company that was established in 2020 with a mission to offer world-class products and customer experience. The company is based in the United States and has subsidiaries in Canada and the United States. The company has built a portfolio of high-quality products and brands serving various life sciences end markets, including diagnostic, therapeutic, and research. Fortis Life Sciences offers word-class reagents, tools, materials, and custom services for their research, diagnostic, and therapeutic customers. The company was founded in 2020 by Brian S. Kim and Ken Yoon, with Brian S. Kim serving as the CEO since then.

Accellix, Inc. develops in-vitro diagnostic systems. Its Accellix platform is an affordable tabletop diagnostic device with single-use assay cartridges that does not require extensive training nor involve complex operational processes. The firm’s product is an application for the rapid identification of sepsis, a condition associated with high morbidity and mortality with no existing rapid diagnostic test. The company was founded in 2009 by Julien Meissonnier and Harvey Kasdan and is headquartered in San Jose, CA.

Fortis Life Sciences LLC is an American life sciences company that was established in 2020 with a mission to offer world-class products and customer experience. The company is based in the United States and has subsidiaries in Canada and the United States. The company has built a portfolio of high-quality products and brands serving various life sciences end markets, including diagnostic, therapeutic, and research. Fortis Life Sciences offers word-class reagents, tools, materials, and custom services for their research, diagnostic, and therapeutic customers. The company was founded in 2020 by Brian S. Kim and Ken Yoon, with Brian S. Kim serving as the CEO since then.